Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Simon

Showing results (141-150 of 494) with videos related to

Pageof 50
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
Microsatellite DNA alterations of gastrointestinal stromal tumors are predictive for outcomePaulus Schurr, Stefan Wolter, Jussuf Kaifi, et al.
Oncotarget|December 20, 2015
Heterogeneity and chronology of 6q15 deletion and ERG-fusion in prostate cancerMartina Kluth, David Meyer, Antje Krohn, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 18, 2012
Marked heterogeneity of ERG expression in large primary prostate cancersSarah Minner, Michael Gärtner, Fabian Freudenthaler, et al.
Cancers|September 28, 2024
The 3-Biomarker Classifier-A Novel and Simple Molecular Risk Score Predicting Overall Survival in Patients with Colorectal CancerNathaniel Melling, Mohammad H Fard-Aghaie, Claudia Hube-Magg, et al.
Cells|October 27, 2020
Discovery of Targetable Genetic Alterations in NSCLC Patients with Different Metastatic Patterns Using a MassARRAY-Based Circulating Tumor DNA AssayYassine Belloum, Melanie Janning, Malte Mohme, et al.
Cancer Genetics|May 24, 2014
Reduced membranous MET expression is linked to bladder cancer progressionMartina Kluth, Kristina Reynolds, Michael Rink, et al.
The Prostate|September 30, 2011
Y chromosome losses are exceedingly rare in prostate cancer and unrelated to patient agePhillip R Stahl, Adisa Kilgué, Pierre Tennstedt, et al.
Anticancer Research|November 14, 2013
Concordance of HER2 status in primary tumour and lymph node metastases in patients with esophageal carcinomaAlexandra M König, Matthias Reeh, Ana-Maria Dancau, et al.
Nature Genetics|April 10, 2007
Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancerFrederik Holst, Phillip R Stahl, Christian Ruiz, et al.
International Journal of Cancer|December 7, 2005
Tissue microarrays for comparing molecular features with proliferation activity in breast cancerChristian Ruiz, Silvia Seibt, Khawla Al Kuraya, et al.
Pageof 50

Showing results (141-150 of 494) with videos related to

Sort By:
Pageof 50
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
Microsatellite DNA alterations of gastrointestinal stromal tumors are predictive for outcomePaulus Schurr, Stefan Wolter, Jussuf Kaifi, et al.
Oncotarget|December 20, 2015
Heterogeneity and chronology of 6q15 deletion and ERG-fusion in prostate cancerMartina Kluth, David Meyer, Antje Krohn, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 18, 2012
Marked heterogeneity of ERG expression in large primary prostate cancersSarah Minner, Michael Gärtner, Fabian Freudenthaler, et al.
Cancers|September 28, 2024
The 3-Biomarker Classifier-A Novel and Simple Molecular Risk Score Predicting Overall Survival in Patients with Colorectal CancerNathaniel Melling, Mohammad H Fard-Aghaie, Claudia Hube-Magg, et al.
Cells|October 27, 2020
Discovery of Targetable Genetic Alterations in NSCLC Patients with Different Metastatic Patterns Using a MassARRAY-Based Circulating Tumor DNA AssayYassine Belloum, Melanie Janning, Malte Mohme, et al.
Cancer Genetics|May 24, 2014
Reduced membranous MET expression is linked to bladder cancer progressionMartina Kluth, Kristina Reynolds, Michael Rink, et al.
The Prostate|September 30, 2011
Y chromosome losses are exceedingly rare in prostate cancer and unrelated to patient agePhillip R Stahl, Adisa Kilgué, Pierre Tennstedt, et al.
Anticancer Research|November 14, 2013
Concordance of HER2 status in primary tumour and lymph node metastases in patients with esophageal carcinomaAlexandra M König, Matthias Reeh, Ana-Maria Dancau, et al.
Nature Genetics|April 10, 2007
Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancerFrederik Holst, Phillip R Stahl, Christian Ruiz, et al.
International Journal of Cancer|December 7, 2005
Tissue microarrays for comparing molecular features with proliferation activity in breast cancerChristian Ruiz, Silvia Seibt, Khawla Al Kuraya, et al.
Pageof 50